|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> Lorecivivint>> 市场分析报告 |
Lorecivivint市场分析报告 |
|
Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A - Pipeline Review, H2 2019 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A - Pipeline Review, H2 2019 SUMMARY Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A (Serine/Threonine Kinase MNB or MNB/DYRK Protein Kinase or Dual specificity YAK1 Related Kinase ... Osteoarthritis - Pipeline Insight, 2021 ... trial evaluation to treat osteoarthritis. Lorecivivint (SM04690): Biosplice Therapeutics Biosplice ... is also exploring the impact lorecivivint plays on inflammation, function, and ... CartilaGen Key Products Ampion Lorecivivint (SM04690) SB-061 Elixcyte V120083 ... Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A - Pipeline Review, H1 2019 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A - Pipeline Review, H1 2019 SUMMARY Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A (Serine/Threonine Kinase MNB or MNB/DYRK Protein Kinase or Dual specificity YAK1 Related Kinase ... Knee Osteoarthritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major knee osteoarthritis markets reached a value of US$ 4.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 9.1 Billion by 2034, exhibiting a growth rate (CAGR) of 6.18% during 2024-2034. The knee osteoarthritis market has ... |